Kenjiro Sawada Selected Research

Kenjiro Sawada Research Topics

Disease

66	Neoplasms (Cancer) 03/2024 - 11/2002
36	Ovarian Neoplasms (Ovarian Cancer) 04/2024 - 11/2002
14	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023 - 07/2014
12	Neoplasm Metastasis (Metastasis) 03/2024 - 12/2002
10	Carcinoma (Carcinomatosis) 09/2018 - 04/2005
7	Adenocarcinoma 01/2023 - 06/2011
6	Carcinogenesis 01/2023 - 02/2008
5	Ovarian Epithelial Carcinoma 06/2023 - 11/2018
5	Endometrial Neoplasms (Endometrial Cancer) 03/2022 - 02/2015
5	Ascites 01/2015 - 01/2005
4	Osteoporosis 01/2017 - 11/2002
4	Hypoxia (Hypoxemia) 05/2015 - 10/2004
3	Postmenopausal Osteoporosis 01/2020 - 06/2003
3	Infections 03/2016 - 02/2007
2	Uterine Neoplasms (Uterine Cancer) 03/2022 - 01/2018
2	Endometriosis 01/2022 - 08/2016
2	Chorioamnionitis 03/2016 - 11/2013
2	Inflammation (Inflammations) 03/2016 - 11/2013
1	Carcinosarcoma 03/2024
1	Pancreatic Fistula (Pancreatic Fistulas) 03/2024
1	Thrombosis (Thrombus) 05/2023
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2023
1	Genomic Instability 01/2023
1	Anemia 01/2022
1	Fatigue 01/2022
1	Diarrhea 09/2021

Drug/Important Bio-Agent (IBA)

8	MicroRNAs (MicroRNA)IBA 01/2020 - 05/2013
8	Proteins (Proteins, Gene)FDA Link 08/2019 - 11/2002
8	IntegrinsIBA 01/2019 - 02/2007
7	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021 - 07/2014
5	PlatinumIBA 10/2019 - 12/2015
5	Cisplatin (Platino)FDA LinkGeneric 11/2018 - 09/2009
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2016 - 03/2007
5	rho-Associated KinasesIBA 12/2009 - 11/2002
5	lysophosphatidic acidIBA 12/2009 - 11/2002
5	Tyrosine (L-Tyrosine)FDA Link 04/2007 - 11/2002
4	Paclitaxel (Taxol)FDA LinkGeneric 05/2023 - 01/2015
4	Indicators and Reagents (Reagents)IBA 01/2021 - 06/2011
4	Neutralizing AntibodiesIBA 03/2019 - 07/2014
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 11/2013
4	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2009 - 11/2002
3	Small Interfering RNA (siRNA)IBA 04/2024 - 02/2007
3	Bevacizumab (Avastin)FDA Link 10/2023 - 08/2010
3	Estrogens (Estrogen)FDA Link 01/2023 - 01/2018
3	Mevalonic Acid (Mevalonate)IBA 01/2021 - 11/2002
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 06/2014
3	Biomarkers (Surrogate Marker)IBA 09/2018 - 01/2014
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2017 - 02/2007
3	Phosphotransferases (Kinase)IBA 05/2016 - 02/2007
3	Messenger RNA (mRNA)IBA 04/2009 - 10/2004
3	Diphosphonates (Bisphosphonates)IBA 01/2005 - 11/2002
2	Immunoglobulin G (IgG)IBA 10/2023 - 04/2008
2	Plasminogen Activator Inhibitor 1IBA 10/2023 - 10/2017
2	RNA (Ribonucleic Acid)IBA 10/2023 - 07/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2010
2	Dinoprostone (PGE2)FDA Link 12/2020 - 11/2018
2	TOR Serine-Threonine KinasesIBA 12/2020 - 09/2009
2	YM 529IBA 01/2020 - 01/2017
2	PM 01183IBA 10/2019 - 01/2016
2	LipidsIBA 08/2019 - 02/2015
2	Celecoxib (Celebrex)FDA Link 01/2019 - 11/2018
2	VitronectinIBA 11/2018 - 10/2017
2	taxaneIBA 10/2018 - 12/2017
2	Raloxifene Hydrochloride (Evista)FDA Link 01/2017 - 02/2015
2	CytokinesIBA 03/2016 - 11/2013
2	Antineoplastic Agents (Antineoplastics)IBA 01/2016 - 12/2009
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2015 - 11/2013
2	TrabectedinIBA 06/2014 - 07/2011
2	Everolimus FDA Link 07/2011 - 09/2009
2	Oxygen (Dioxygen)IBA 09/2009 - 10/2004
2	Cadherins (E-Cadherin)IBA 09/2009 - 04/2008
2	Peptide Hydrolases (Proteases)FDA Link 02/2008 - 02/2007
2	geranylgeranylacetone (teprenone)IBA 04/2007 - 04/2005
2	NitrogenIBA 01/2005 - 11/2002
1	Amylases FDA Link 03/2024
1	edoxabanIBA 05/2023
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2023
1	Galectin 3 (LGALS3)IBA 01/2022
1	IronIBA 01/2022
1	Asu(1,6)- argipressin (VAS-A)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	ninjin'yoeitoIBA 01/2022
1	Farnesyl-Diphosphate Farnesyltransferase (Squalene Synthase)IBA 01/2021

Therapy/Procedure

23	Therapeutics 01/2022 - 12/2002
8	Drug Therapy (Chemotherapy) 03/2024 - 01/2015
6	Radiotherapy 12/2022 - 07/2014
6	Hysterectomy 10/2017 - 01/2012
3	Aftercare (After-Treatment) 01/2022 - 02/2015
2	Lymph Node Excision (Lymph Node Dissection) 03/2022 - 02/2015
2	Laparotomy 03/2022 - 03/2011
2	Kampo Medicine (Kampo) 01/2022 - 01/2018
2	Brachytherapy 05/2021 - 03/2019
2	Combination Drug Therapy (Combination Chemotherapy) 10/2018 - 12/2017
2	Splenectomy 12/2015 - 07/2014
1	Colectomy 03/2024
1	Gynecologic Surgical Procedures (Gynecologic Surgery) 03/2024
1	Stents 03/2024
1	Minimally Invasive Surgical Procedures 06/2023
1	Adjuvant Chemotherapy 05/2023
1	Chemoradiotherapy 09/2021